6-42704556-A-G
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000322.5(PRPH2):c.637T>C(p.Cys213Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C213F) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000322.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary macular dystrophyInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- PRPH2-related retinopathyInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- Leber congenital amaurosisInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- retinitis pigmentosa 7Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- inherited retinal dystrophyInheritance: SD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen, Ambry Genetics
- choroidal dystrophy, central areolar 2Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- fundus albipunctatusInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- vitelliform macular dystrophy 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- adult-onset foveomacular vitelliform dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- central areolar choroidal dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multifocal pattern dystrophy simulating fundus flavimaculatusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- patterned macular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis punctata albescensInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251452 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
Curator: Global Variome, with Curator vacancy. Submitter to LOVD: Manon Peeters. -
- -
Patterned macular dystrophy 1 Pathogenic:1
- -
Leber congenital amaurosis 18 Pathogenic:1
- -
PRPH2-related disorder Pathogenic:1
This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 213 of the PRPH2 protein (p.Cys213Arg). This variant is present in population databases (rs61755802, gnomAD 0.0009%). This missense change has been observed in individual(s) with autosomal dominant pattern dystrophy and/or autosomal recessive Leber congenital amaurosis (PMID: 9443872, 23847139). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 98691). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PRPH2 protein function with a positive predictive value of 95%. This variant disrupts the p.Cys213 amino acid residue in PRPH2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11934323, 21071739, 28559085). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at